Etihad Cargo, Etihad Airport Services and Abu Dhabi Airports are preparing to launch a new state-of-the-art pharmaceutical cool chain facility at the Abu Dhabi hub
Abu Dhabi, United Arab Emirates – Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, in partnership with Etihad Airport Services and Abu Dhabi Airports, are preparing to launch a new state-of-the-art pharmaceutical cool chain facility. Due to go into operation soon, the facility will significantly expand Abu Dhabi International Airport’s (AUH) pharmaceutical handling and storage.
Etihad Cargo's customers will benefit from the carrier's expanded International Air Transport Association (IATA) Center of Excellence for Independent Validators (CEIV) Pharma certification for pharmaceutical and life science logistics and provision of world-class, end-to-end temperature-controlled solutions for the transportation of pharmaceuticals across the carrier's global network.
Prior to the opening of the new pharmaceutical facility at the carrier's Abu Dhabi hub, Etihad Cargo transported over 50,000 tonnes of cool chain products, including pharmaceutical and healthcare products via its PharmaLife product and fresh produce via its IATA CEIV Fresh-certified FreshForward product, in the past twelve months. The launch of the expanded, dedicated pharmaceutical hub will double Abu Dhabi Airport’s cool chain storage capacity and enhance the airport’s capabilities for the storage, handling and transportation of cool chain products.
"Etihad Cargo is proud to have collaborated closely with Etihad Airport Services and Abu Dhabi Airports to launch the new pharmaceutical storage and handling facility. The expanded infrastructure will offer best-in-class pharmaceutical shipment solutions to Etihad Cargo’s customers and is the latest step in supporting Abu Dhabi's vision to cement its position as a global pharmaceuticals and life sciences hub," said Martin Drew, Senior Vice President Global Sales & Cargo at Etihad Aviation Group. "This joint venture located at Etihad Cargo’s hub at Abu Dhabi International Airport provides the perfect location to link the Middle East to not only Asia and Europe, but also the US and Africa, so life-saving medicines and the latest treatments can be transported seamlessly around the world to those that need them the most. Investment into the carrier's infrastructure and Abu Dhabi hub will enable Etihad Cargo to meet the future challenges of the pharma supply chain and will play a significant role in co-creating a robust and future-proof healthcare ecosystem here in the UAE and around the world."
The additional 3,000 square-metre facility comprises the latest technology and features, including bulk loading docks with levellers, high-speed roll-up shutters, insulation and a real-time temperature monitoring system, which will enable faster and more efficient loading with stricter temperature controls, increased storage space, additional build-up and breakdown zones for improved production workflows and upgraded cool chain facilities for Etihad Cargo's PharmaLife handling and storage operations. The new facility will also feature new x-ray screening for customs inspections within a fully temperature-controlled environment and new dedicated thermal covers.
Steven Polmans, Vice President of Business Development & Regulatory Affairs at Abu Dhabi Airports Free Zone (ADAFZ) said, "The upcoming launch of this dedicated pharmaceuticals storage and handling facility will enhance AUH’s capabilities as a cargo hub and aligns with Abu Dhabi's vision of becoming a global business, pharmaceutical and life science hub. The strong collaboration between Etihad Cargo, Etihad Airport Services and Abu Dhabi Airports will continue to increase pharmaceutical cargo volumes and further position Abu Dhabi as a major solutions provider in the logistics supply chain."
The new cool chain facility will enable the safe storage and handling of a vast range of pharmaceutical products requiring different temperatures and conditions. To meet the requirements for transporting dangerous goods in frozen and deep-frozen conditions, PharmaLife provides premium tailored solutions to handle temperature-controlled conditions from -80 to 25 degrees Celsius via the carrier's portfolio of leased active and hybrid containers. Etihad Cargo also utilises traditional containers that meet standard temperature requirements, from 2 to 8 and 15 to 25 degrees Celsius.
Jubran Al Breiki, General Manager at Etihad Airport Services – Ground & Cargo, said, "This state-of-the-art pharmaceutical facility has been made possible through the partnership between Etihad Airport Services, Etihad Cargo and Abu Dhabi Airports and the expertise each brings to a project of this scale. In addition to offering a fully equipped pharmaceuticals centre, temperature-controlled rooms and 24/7 end-to-end cargo support, the innovative systems within the facility enable pharmaceuticals to be effectively tracked and traced. This benefits Etihad Cargo's customers and all other stakeholders with greater transparency, real-time status updates and makes the transportation of cargo quicker and more efficient."
From the newly established pharmaceuticals hub, Etihad Cargo will continue to work closely with customers and partners to ensure the smooth, efficient, safe and on-time delivery of pharmaceuticals and life sciences products. To meet the requirements of personalised medication and treatment, including cell and gene therapies, Etihad Cargo is exploring the utilisation of artificial intelligence to improve forecasting and automation to enhance the carrier's current capacity and capabilities.
Via the expanded cool chain facility, Etihad Cargo will also be further investing in sustainable solutions to make the transportation of pharmaceuticals more environmentally friendly, in line with Etihad Aviation Group's sustainability plans and pledge to achieve net-zero carbon emissions by 2050. The carrier has already replaced 3,000 containers from its original aluminium unit load device (ULD) fleet with a more environmentally friendly, lightweight version. More recently, Etihad Cargo entered into a memorandum of understanding (MOU) with B Medical Systems to develop and launch the world's first airline-specific passive temperature-controlled container. In the coming months, Etihad Cargo will be participating in Pharma. Aero's green pharma lane project, expanding on the successful launch of Pharma Corridor 2.0.
-Ends-
About Etihad Cargo:
Etihad Cargo is the cargo and logistics arm of the Etihad Aviation Group. Since its establishment in 2004, Etihad Cargo has grown rapidly to become one of the leading air cargo carriers in the world, offering customers a range of cargo products and services to five major continents. Its hub in Abu Dhabi is strategically located at the centre of the world's busiest trade lanes, providing an integral link between Asia, Europe, North America, Australia and Africa.
In addition to general cargo, Etihad Cargo offers a wide range of specialty products including live animals, dangerous goods, valuables and vulnerables, personal effects, as well as its market leading cold chain products (the latter holding IATA's stringent Centre of Excellence for Independent Validators certifications for both Pharmaceutical and Perishables Logistics, as well as Live Animals Logistics).
For more information, please visit www.etihadcargo.com
Media Contacts:
Duty Media Officer, Etihad Aviation Group
Email: dutymediaofficer@etihad.ae
Christina Bostock, IHC (Etihad Cargo)
Email: christina@ih-c.com
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
Discover more